RT @of_aic: Most cited COVID-19 article: a state-of-the art on therapeutics in COVID-19 patients https://t.co/pmQjeNEtHa https://t.co/hwB6t…
Most cited COVID-19 article: a state-of-the art on therapeutics in COVID-19 patients https://t.co/pmQjeNEtHa https://t.co/hwB6tUrwVQ #COVID-19Therapeutics #AIC #SRLF #FICS https://t.co/5lPVQwkAbv
RT @of_aic: Most cited COVID-19 article: a state-of-the art on therapeutics in COVID-19 patients https://t.co/g3AYqixdR4 https://t.co/ydJc…
Most cited COVID-19 article: a state-of-the art on therapeutics in COVID-19 patients https://t.co/g3AYqixdR4 https://t.co/ydJcXEKurQ #COVID-19Therapeutics #AIC #SRLF #FICS https://t.co/V0UTTBATxq
@alex22627455 @DavidSteadson @NonProphet75 @craniosurgeon @GCarty80 @Nils_Littorin @FatEmperor @PGtzsche1 @MLevitt_NP2013 Amazingly enough, this paper actually includes a claim that high flow nasal cannula should be used over ventilation, as it leads to lo
RT @petita_libelula: Therapeutic strategies for critically ill patients with COVID-19 https://t.co/mXmnyHd6Fm
RT @petita_libelula: Therapeutic strategies for critically ill patients with COVID-19 https://t.co/mXmnyHd6Fm
Therapeutic strategies for critically ill patients with COVID-19 https://t.co/mXmnyHd6Fm
RT @OrlandoRPN: Estrategias terapéuticas para #COVID19, la evidencia de los fármacos, léanlo a conciencia: https://t.co/sARgD6L1n7
RT @OrlandoRPN: Estrategias terapéuticas para #COVID19, la evidencia de los fármacos, léanlo a conciencia: https://t.co/sARgD6L1n7
RT @yodagreenemd: Therapeutic strategies for critically ill patients with COVID-19 | Annals of Intensive Care | Full Text https://t.co/V8M9…
RT @OrlandoRPN: Estrategias terapéuticas para #COVID19, la evidencia de los fármacos, léanlo a conciencia: https://t.co/sARgD6L1n7
RT @OrlandoRPN: Estrategias terapéuticas para #COVID19, la evidencia de los fármacos, léanlo a conciencia: https://t.co/sARgD6L1n7
RT @OrlandoRPN: Estrategias terapéuticas para #COVID19, la evidencia de los fármacos, léanlo a conciencia: https://t.co/sARgD6L1n7
RT @OrlandoRPN: Estrategias terapéuticas para #COVID19, la evidencia de los fármacos, léanlo a conciencia: https://t.co/sARgD6L1n7
RT @OrlandoRPN: Estrategias terapéuticas para #COVID19, la evidencia de los fármacos, léanlo a conciencia: https://t.co/sARgD6L1n7
RT @OrlandoRPN: Estrategias terapéuticas para #COVID19, la evidencia de los fármacos, léanlo a conciencia: https://t.co/sARgD6L1n7
RT @OrlandoRPN: Estrategias terapéuticas para #COVID19, la evidencia de los fármacos, léanlo a conciencia: https://t.co/sARgD6L1n7
RT @OrlandoRPN: Estrategias terapéuticas para #COVID19, la evidencia de los fármacos, léanlo a conciencia: https://t.co/sARgD6L1n7
RT @OrlandoRPN: Estrategias terapéuticas para #COVID19, la evidencia de los fármacos, léanlo a conciencia: https://t.co/sARgD6L1n7
RT @OrlandoRPN: Estrategias terapéuticas para #COVID19, la evidencia de los fármacos, léanlo a conciencia: https://t.co/sARgD6L1n7
RT @OrlandoRPN: Estrategias terapéuticas para #COVID19, la evidencia de los fármacos, léanlo a conciencia: https://t.co/sARgD6L1n7
RT @OrlandoRPN: Estrategias terapéuticas para #COVID19, la evidencia de los fármacos, léanlo a conciencia: https://t.co/sARgD6L1n7
RT @yodagreenemd: Therapeutic strategies for critically ill patients with COVID-19 | Annals of Intensive Care | Full Text https://t.co/V8M9…
Therapeutic strategies for critically ill patients with COVID-19 | Annals of Intensive Care | Full Text https://t.co/V8M9AU4Ua6
RT @OrlandoRPN: Estrategias terapéuticas para #COVID19, la evidencia de los fármacos, léanlo a conciencia: https://t.co/sARgD6L1n7
RT @OrlandoRPN: Estrategias terapéuticas para #COVID19, la evidencia de los fármacos, léanlo a conciencia: https://t.co/sARgD6L1n7
RT @OrlandoRPN: Estrategias terapéuticas para #COVID19, la evidencia de los fármacos, léanlo a conciencia: https://t.co/sARgD6L1n7
RT @OrlandoRPN: Estrategias terapéuticas para #COVID19, la evidencia de los fármacos, léanlo a conciencia: https://t.co/sARgD6L1n7
Estrategias terapéuticas para #COVID19, la evidencia de los fármacos, léanlo a conciencia: https://t.co/sARgD6L1n7
Therapeutic #strategies for critically ill patients with #COVID-19 | Annals of Intensive Care | Full Text https://t.co/6hS1BYTYrg
"The efficacy of existing drugs as well as adjunctive pharmacologic interventions in the treatment of critical ill patients with COVID-19 warrants further verification in clinical research." https://t.co/2v2zezgTzA
RT @ClinMedJournals: #AIC #OpenAccess https://t.co/CVx3gz8rfZ #Drugs, #adjunctive agents, #respiratory strategies, circulation management,…
RT @Alzhacker: COVID-19重症患者のための治療戦略 https://t.co/imZbJWuqh8
RT @Alzhacker: COVID-19重症患者のための治療戦略 https://t.co/imZbJWuqh8
RT @ClinMedJournals: #AIC #OpenAccess https://t.co/CVx3gz8rfZ #Drugs, #adjunctive agents, #respiratory strategies, circulation management,…
RT @ClinMedJournals: #AIC #OpenAccess https://t.co/CVx3gz8rfZ #Drugs, #adjunctive agents, #respiratory strategies, circulation management,…
@EffieGib Hydroxychloroquine sulfate 400 mg given twice daily for 1 day, followed by 200 mg twice daily for another 4 days is recommended in the treatment COVID-19” https://t.co/cb9388fPss The University of Oxford is currently conducting a controlled 40,
#AyudaBiblioteca Therapeutic strategies for critically ill patients with COVID-19 https://t.co/jMzbOPZIK7 https://t.co/SFMNXmfmBA
RT @Alzhacker: COVID-19重症患者のための治療戦略 https://t.co/imZbJWuqh8
COVID-19重症患者のための治療戦略 https://t.co/imZbJWuqh8
RT @CIMSFHUVH: Therapeutic strategies for critically ill patients with COVID-19 https://t.co/PI5urtssjy
Therapeutic strategies for critically ill patients with COVID-19 https://t.co/PI5urtssjy
RT @ClinMedJournals: #AIC #OpenAccess https://t.co/CVx3gz8rfZ #Drugs, #adjunctive agents, #respiratory strategies, circulation management,…
#AIC #OpenAccess https://t.co/CVx3gz8rfZ #Drugs, #adjunctive agents, #respiratory strategies, circulation management, multiple #organ function monitoring & #nutrition for the treatment of #COVID19 #FOAMEd #FOAMcc #intensivecare #ICU #coronavirus #pand
@RobWack @DrDenaGrayson "Hydroxychloroquine sulfate 400 mg given twice daily for 1 day, followed by 200 mg twice daily for another 4 days is recommended in the treatment COVID-19" https://t.co/UPgGG6bAD4 The University of Oxford is currently conducting a c
Therapeutic strategies for critically ill patients with COVID-19 https://t.co/4YQaBIxA5l